Israel Englander Allakos Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.0 - $1.45 $38,600 - $55,970
-38,600 Reduced 69.68%
16,800 $16,000
Q1 2024

May 15, 2024
SELL
$1.02 - $3.23 $134,334 - $425,391
-131,700 Reduced 70.39%
55,400 $69,000
Q4 2023

Feb 14, 2024
BUY
$1.72 - $3.18 $321,812 - $594,978
187,100 New
187,100 $510,000

Others Institutions Holding ALLK

# of Institutions
96
Shares Held
70.7M
Call Options Held
43.8K
Put Options Held
1.4K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $119M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email